PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24378685-6	2014	CAPE significantly and dose-dependently reduced LPS-induced nitrite production, as well as the transcription and protein synthesis of monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6) and inducible nitric oxide synthase (iNOS), as determined by quantitative reverse transcription-polymerase chain reaction (qRT-PCR), western blotting and enzyme-linked immunosorbent assays (ELISA).	caffeic acid phenethyl ester	0-4	interleukin 6	Rattus norvegicus	178-191	
24378685-6	2014	CAPE significantly and dose-dependently reduced LPS-induced nitrite production, as well as the transcription and protein synthesis of monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6) and inducible nitric oxide synthase (iNOS), as determined by quantitative reverse transcription-polymerase chain reaction (qRT-PCR), western blotting and enzyme-linked immunosorbent assays (ELISA).	caffeic acid phenethyl ester	0-4	interleukin 6	Rattus norvegicus	193-197	
16983503-4	2006	The levels of tumor necrosis factor-alpha, interleukin-6, and interleukin-1alpha in the caffeic acid phenethyl ester group were significantly lower than those in the bile duct ligation group (P < 0.03, P < 0.01, and P < 0.02 respectively).	caffeic acid phenethyl ester	88-116	interleukin 6	Rattus norvegicus	43-56	
19535096-8	2010	In CAPE treated group, the levels of interleukin-1alpha (IL-1alpha) and interleukin-6 (IL-6) were significantly lower than that of BDL group (P < 0.03, P < 0.02, respectively).	caffeic acid phenethyl ester	3-7	interleukin 6	Rattus norvegicus	72-85	
19535096-8	2010	In CAPE treated group, the levels of interleukin-1alpha (IL-1alpha) and interleukin-6 (IL-6) were significantly lower than that of BDL group (P < 0.03, P < 0.02, respectively).	caffeic acid phenethyl ester	3-7	interleukin 6	Rattus norvegicus	87-91	
34754212-8	2021	More interestingly, the one-way ANOVA data demonstrated a decreased level of proinflammatory IL-6 in the CAPE-treated group compared to the negative control.	caffeic acid phenethyl ester	105-109	interleukin 6	Rattus norvegicus	93-97	
14751512-9	2004	CAPE treatment inhibited the radiation-induced expression of IL-6, IL-6 receptors (IL-6rs), and SOCS3 at 3 days.	caffeic acid phenethyl ester	0-4	interleukin 6	Rattus norvegicus	61-65	
14751512-9	2004	CAPE treatment inhibited the radiation-induced expression of IL-6, IL-6 receptors (IL-6rs), and SOCS3 at 3 days.	caffeic acid phenethyl ester	0-4	interleukin 6	Rattus norvegicus	67-71	
31059064-5	2019	In addition, CAPE decreased the severity of inflammation in the retina, reflected by the decreased expression of inflammatory cytokines, including interleukin (IL)-8, IL-6, inducible nitric oxide synthase, cycloooxygenase-2, tumor necrosis factor-alpha and chemokine C-C ligand-2, in CAPE-treated rats.	caffeic acid phenethyl ester	13-17	interleukin 6	Rattus norvegicus	167-171	
26044239-7	2015	RESULTS: In CAPE treated group, decreased serum levels of proinflammatory cytokines (TNF-alpha, IL-6, IL-1beta) and CRP (p < 0.05), additionally increased serum levels of antioxidant parameters (PONS, TAS) (p < 0.05), were observed after IO.	caffeic acid phenethyl ester	12-16	interleukin 6	Rattus norvegicus	96-100	
30192364-0	2018	Effects of Intrathecal Caffeic Acid Phenethyl Ester (CAPE) on IL-6 and TNF-α Levels and Local Inflammatory Responses in Spinal Cord Injuries.	caffeic acid phenethyl ester	23-51	interleukin 6	Rattus norvegicus	62-66	
30192364-0	2018	Effects of Intrathecal Caffeic Acid Phenethyl Ester (CAPE) on IL-6 and TNF-α Levels and Local Inflammatory Responses in Spinal Cord Injuries.	caffeic acid phenethyl ester	53-57	interleukin 6	Rattus norvegicus	62-66	
30192364-1	2018	AIM: To investigate the effects of intrathecal caffeic acid phenethyl ester (CAPE) on tissue and serum interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-?) levels following spinal cord injury (SCI) as well as its effects on edema and microhemorrhage.	caffeic acid phenethyl ester	47-75	interleukin 6	Rattus norvegicus	103-116	
30192364-1	2018	AIM: To investigate the effects of intrathecal caffeic acid phenethyl ester (CAPE) on tissue and serum interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-?) levels following spinal cord injury (SCI) as well as its effects on edema and microhemorrhage.	caffeic acid phenethyl ester	77-81	interleukin 6	Rattus norvegicus	103-116	
30192364-1	2018	AIM: To investigate the effects of intrathecal caffeic acid phenethyl ester (CAPE) on tissue and serum interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-?) levels following spinal cord injury (SCI) as well as its effects on edema and microhemorrhage.	caffeic acid phenethyl ester	77-81	interleukin 6	Rattus norvegicus	118-122	
30192364-9	2018	RESULTS: The decrease in IL-6 levels in the CAPE group was significantly higher than that in the sham and control groups.	caffeic acid phenethyl ester	44-48	interleukin 6	Rattus norvegicus	25-29	
30192364-14	2018	CONCLUSION: Intrathecal CAPE administration following SCI decreases tissue and serum IL-6 levels as well as decreases spinal cord edema and microhemorrhage.	caffeic acid phenethyl ester	24-28	interleukin 6	Rattus norvegicus	85-89